Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Adenomatous Polyposis Coli 2Pathologic Complete Response 1Pancreatic Intraductal Neoplasms 1Pain 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Inflammation 1Hypertension 1Coproporphyria 1Aberrant Crypt Foci 1

Interventions

Photochemotherapy 2Metformin 2Biopsy 2Tomography, Optical Coherence 1Tobacco Products 1Surveys and Questionnaires 1Sulindac 1Specimen Handling 1Photosensitizing Agents 1Nivolumab 1Melatonin 1Fluorouracil 1Fluconazole 1Ethanol 1Dihematoporphyrin Ether 1Celecoxib 1Catechin 1Behavior Therapy 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukoplakia, Oral × Sulindac × Clear all
NCT00299195 2020-11-19

A Randomized Study of Sulindac in Oral Premalignant Lesions

Memorial Sloan Kettering Cancer Center

Phase NA Completed
63 enrolled 10 charts
Head & Neck

Coproporphyria, Leukoplakia, Oral, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡